India's national pharmacovigilance programme is the Pharmacovigilance Programme of India (PvPI), coordinated by the Indian Pharmacopoeia Commission (IPC) within the national medicines regulatory framework involving CDSCO.
Core official resources
- PvPI adverse drug reaction reporting — official reporting forms, reporting information and links to ADR Monitoring Centres.
- Indian Pharmacopoeia Commission — IPC institutional site and PvPI resources.
- Central Drugs Standard Control Organisation — India's national medicines regulatory authority portal for regulatory notices, rules, guidance and forms.
Practical use
Use PvPI resources for national pharmacovigilance programme information and ADR reporting. For marketing-authorisation-holder obligations, verify the current Drugs and Cosmetics regulatory framework and current CDSCO notices/guidance rather than assuming PvPI reporting material alone defines all company obligations.